← Back to Search

Audit-and-feedback for Urological Diseases

N/A

Waitlist Available

Research Sponsored by Iowa City Veterans Affairs Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 30-days of the urologic procedure

Awards & highlights

Study Summary

This trial will test whether giving feedback to providers at 3 VHA hospitals can reduce unnecessary antimicrobial use after urologic procedures.

Eligible Conditions

Antibiotic Adverse Reaction
Urological Diseases

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 30-days of the urologic procedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 30-days of the urologic procedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 30-days of the urologic procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of cases who received excessive post-procedural antimicrobials

Secondary outcome measures

Excessive post-procedural antimicrobial duration (mean)

Proportion of cases who acquired Clostridioides difficile infection

Proportion of cases who died (mortality)

+3 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: InterventionExperimental Treatment1 Intervention

We will randomly select 3 intervention sites from the top quartile of all VHA sites, as ranked by the frequency of excessive post-procedural antimicrobial use after the 3 urologic procedures of interest. We will provide feedback both at baseline and at regular intervals to the 3 intervention sites. Data on hospital-level excessive post-procedural antimicrobial use specific to urologic patients (primary outcome) will be shared at baseline with the intervention sites. Updated data will be sent electronically to urology providers and the antimicrobial stewardship team at the intervention site every other month via electronic mail. These data will include an anonymous comparison to all other VHA hospitals.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Audit-and-feedback

2022

N/A

~9280

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Iowa City Veterans Affairs Medical CenterLead Sponsor

6 Previous Clinical Trials

1,181 Total Patients Enrolled

Merck Investigator Studies ProgramUNKNOWN

2 Previous Clinical Trials

4,801 Total Patients Enrolled

Media Library

Audit-and-feedback 2023 Treatment Timeline for Medical Study. Trial Name: NCT04196777 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can patients currently enroll in this research experiment?

"As per the information on clinicaltrials.gov, this medical trial is not taking participants presently. The trial was first published on August 1st 2022 and last edited on October 17th 2022. Even though recruitment has ended for this specific study, there are 67 other studies that are now enrolling patients into their trials."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Audit-and-feedback to Improve Antimicrobial-prescribing Among Urologists

Daniel Livorsi 2022. "Audit-and-feedback to Improve Antimicrobial-prescribing Among Urologists". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04196777.